Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 307

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 307
---
 or disclosure in the financial statements, except for the below:

On July 1, 2025, the Company entered
into amendments of the Bridge Loans, the January 2024 Loan, the December 2024 Loan Agreement and the April 2025 Loan Agreements such
that the lenders party thereto shall be granted with a fixed number of warrants to purchase such number of Ordinary Shares following
the consummation of a Qualified IPO, in amounts of 140,000 warrants, 61,539 warrants, 55,224 warrants and 92,309 warrants, respectively.

During September 2025, the Company
entered into amendments of the 2020 Notes agreement, Bridge Loans, the January 2024 Loan, the December 2024 Loan Agreement and the April
2025 Loan Agreements to extend the maturity date until November 30, 2025.

<div align='center'>F-48

1,000,000 Ordinary Shares

Regentis Biomaterials Ltd.</div>

| PRELIMINARY PROSPECTUS |

<div align='center'>ThinkEquity

, 2025</div>

Through and including ,
2025 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating
in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to a dealer’s obligation to
deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.

<div align='center'>PART II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 6. Indemnification of Directors, Officers and Employees.

Under the Companies Law,
a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an
office holder in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach
of the duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our amended and
restated articles of association to be in effect upon completion of this offering include such a provision. The Company may not exculpate
in advance a director from liability arising out of a prohibited dividend or distribution to shareholders.

Under the Companies Law and
the Securities Law, a company may indemnify, or undertake in advance to indemnify